feb 23, 2012 - Ado-Trastuzumab Emtansine (T-DM1) Approved
Description:
FDA approves Ado-Trastuzumab Emtansine (T-DM1) for the treatment of patients with metastatic HER2-positive breast cancer. HER2 makes up 20% of all cases for breast cancer.
Added to timeline:
Cancer Timeline
Date:
